SCHEMBL18615328

SCHEMBL18615328

Cc1ccc(NC(=O)Nc2ccc(C)c(Oc3ccc(C#N)c(Cl)c3)c2)cc1Oc1ccc(C#N)c(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.60
KDR P35968 2/20 0.51
IMPDH2 P12268 2/20 0.50
PGR P06401 2/20 0.49
PLA2G7 Q13093 5/20 0.48
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
BRAF P15056 1/20 0.46
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
SLC22A12 Q96S37 1/20 0.45
MAPT P10636 1/20 0.44
BLM P54132 1/20 0.44
CDK8 P49336 1/20 0.43
IMPDH1 P20839 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18615552 0.94 AR (0.54) ARKDRIMPDH2PGRPLA2G7
SCHEMBL18615546 0.91 AR (0.50) ARKDRIMPDH2PGRPLA2G7
SCHEMBL28913547 0.91 AR (0.57) ARKDRIMPDH2PGRPLA2G7
SCHEMBL18615960 0.89 IMPDH2 (0.53) ARKDRIMPDH2PLA2G7NPC1
SCHEMBL18615355 0.86 IMPDH2 (0.53) ARKDRIMPDH2PLA2G7NPC1
SCHEMBL18615698 0.86 IMPDH2 (0.50) ARKDRIMPDH2PLA2G7NPC1
SCHEMBL18615371 0.82 KDR (0.56) ARKDRPLA2G7BRAF
SCHEMBL14684311 0.81 MAPT (0.67) IMPDH2PLA2G7NPC1RAB9ASMN1; SMN2
SCHEMBL18615537 0.81 KDR (0.55) KDRPLA2G7BRAFCDK8
SCHEMBL18615699 0.80 IMPDH2 (0.45) KDRIMPDH2PLA2G7BRAFSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745346-B2 Agonists of protein tyrosine phosphatase SHP-1 NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) 2020-08-18 US disclosed
US-10745346-B2 Agonists of protein tyrosine phosphatase SHP-1 NATIONAL YANG MING CHIAO TUNG UNIVERSITY (TW) 2020-08-18 US disclosed
US-20180237385-A1 AGONISTS OF PROTEIN TYROSINE PHOSPHATASE SHP-1 NATIONAL TAIWAN UNIVERSITY (TW) 2018-08-23 US disclosed
EP-3345894-A1 COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY Chen, Kuenfeng (TW) 2018-07-11 EP disclosed
WO-2017036405-A1 COMPOUND HAVING PROTEIN TYROSINE PHOSPHATASE SHP-1 AGONIST ACTIVITY 陈昆锋 2017-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180237385-A1 AGONISTS OF PROTEIN TYROSINE PHOSPHATASE SHP-1 PTPRCAP, PTPN18, PTPN1 AR 1296/4885KDR 621/4885IMPDH2 3325/4885
US-10745346-B2 Agonists of protein tyrosine phosphatase SHP-1 PTPRCAP, PTPN18, PTPN1 AR 1296/4885KDR 621/4885IMPDH2 3325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.